361 related articles for article (PubMed ID: 12144908)
1. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
[TBL] [Abstract][Full Text] [Related]
5. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Mol Biol Rep; 1996; 23(3-4):235-42. PubMed ID: 9112234
[TBL] [Abstract][Full Text] [Related]
7. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
Kanzler S; Weidemann C; Gerken G; Löhr HF; Galle PR; Meyer zum Büschenfelde KH; Lohse AW
J Hepatol; 1999 Oct; 31(4):635-40. PubMed ID: 10551386
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of clinical and laboratory indexes in patients with liver disease with positive anti-liver cytosol antibody].
Zhang HP; Yan HP; Lou JL; Huang CY; Ma YX; Li LJ; Han Y; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1182-1187. PubMed ID: 35045634
[No Abstract] [Full Text] [Related]
10. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune hepatitis.
Obermayer-Straub P; Strassburg CP; Manns MP
J Hepatol; 2000; 32(1 Suppl):181-97. PubMed ID: 10728804
[TBL] [Abstract][Full Text] [Related]
12. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.
Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L
Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies and their antigens in autoimmune hepatitis.
Bogdanos DP; Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
[TBL] [Abstract][Full Text] [Related]
14. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
Obermayer-Straub P; Strassburg CP; Manns MP
Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
[TBL] [Abstract][Full Text] [Related]
15. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease.
Han S; Tredger M; Gregorio GV; Mieli-Vergani G; Vergani D
Hepatology; 1995 Jan; 21(1):58-62. PubMed ID: 7806169
[TBL] [Abstract][Full Text] [Related]
16. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.
Rigopoulou EI; Mytilinaiou M; Romanidou O; Liaskos C; Dalekos GN
J Autoimmune Dis; 2007 Feb; 4():2. PubMed ID: 17274827
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria of autoimmune hepatitis.
Liberal R; Grant CR; Longhi MS; Mieli-Vergani G; Vergani D
Autoimmun Rev; 2014; 13(4-5):435-40. PubMed ID: 24418295
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
20. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
